GlassScriptPhysician profile
Richard D David
NPI 1427158245
$263,418.39
in general payments reported to CMS, 2019-2025
68 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $32K · 2021: $16K · 2022: $41K · 2023: $55K · 2024: $25K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Honoraria: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $9,806 · Food and Beverage: $9,679 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,493.50 |
| Honoraria | $25,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,635.00 |
| Travel and Lodging | $9,805.54 |
| Food and Beverage | $9,678.54 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $96,503.42 | 2019-2025 | Xtandi, Myrbetriq |
| Accord Healthcare, INC. | $54,082.93 | 2022-2025 | |
| Butterfly Network, INC. | $34,707.00 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21,357.53 | 2019-2025 | |
| Sn Holdings, LLC | $14,954.15 | 2021-2024 | |
| Pfizer INC. | $6,639.10 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $6,108.95 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Astrazeneca Pharmaceuticals LP | $5,729.32 | 2021-2025 | Lynparza |
| Urogpo LLC | $4,623.28 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $3,495.62 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $1,980.26 | 2019-2025 | Provenge |
| Stryker Corporation | $1,600.00 | 2020-2022 | |
| Janssen Biotech, INC. | $1,026.09 | 2019-2025 | Erleada, Akeega, Balversa |
| Neotract INC. | $949.50 | 2019 | |
| Janssen Scientific Affairs, LLC | $842.18 | 2022-2023 | Erleada |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.56 | 2019-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $701.23 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $660.67 | 2019-2025 | Posluma |
| Antares Pharma, INC. | $654.28 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Sun Pharmaceutical Industries INC. | $563.26 | 2019-2025 | Yonsa |
| Clarus Therapeutics INC. | $444.24 | 2021 | |
| Myriad Genetic Laboratories, INC. | $376.95 | 2020-2022 | |
| Teleflex LLC | $375.91 | 2021-2025 | Barrigel, Urolift |
| Endo Pharmaceuticals INC. | $313.45 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $303.53 | 2019-2024 | Porges Coloplast |
| Verity Pharmaceuticals INC. | $298.81 | 2021-2025 | Tlando, Trelstar |
| Myovant Sciences INC. | $239.97 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $228.77 | 2019-2022 | |
| Procept Biorobotics Corporation | $212.70 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $199.86 | 2020-2022 | |
| Telix Pharmaceuticals | $185.34 | 2024-2025 | Illuccix |
| Urogen Pharma, INC. | $184.48 | 2021-2025 | Jelmyto |
| Foundation Medicine, INC. | $166.02 | 2020-2023 | |
| Allergan, INC. | $161.94 | 2019-2021 | |
| Boston Scientific Corporation | $150.32 | 2019-2025 | Ams 700 |
| Progenics Pharmaceuticals, INC. | $146.67 | 2021-2024 | Pylarify |
| Axonics, INC. | $139.11 | 2020-2023 | Bulkamid, Axonics |
| Valencia Technologies Corporation | $138.99 | 2023-2025 | Ecoin Device Kit |
| Medtronic USA, INC. | $132.99 | 2019 | |
| Angiodynamics, INC. | $120.83 | 2021-2023 | Nanoknife |
| Tolmar, INC. | $98.95 | 2023-2024 | |
| Olympus America INC. | $90.82 | 2021-2025 | Itind System |
| Immunitybio, INC. | $86.23 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $83.77 | 2023-2025 | |
| Endo USA, INC. | $75.67 | 2024-2025 | Xiaflex, Aveed |
| Abc Home Medical Supply, INC. | $63.61 | 2022-2023 | |
| Urovant Sciences INC | $43.94 | 2022 | |
| Travere Therapeutics, INC. | $42.71 | 2019-2021 | |
| Halozyme INC | $42.54 | 2023 | |
| Photocure INC | $41.28 | 2019 | |
| Profound Medical Corp. | $28.81 | 2020 | |
| Palette Life Sciences, INC. | $27.00 | 2022 | |
| Richard Wolf Medical Instruments Corp. | $25.13 | 2019 | |
| Azurity Pharmaceuticals, INC. | $24.76 | 2025 | Azmiro |
| Metuchen Pharmaceuticals | $24.08 | 2020 | |
| Calyxo, INC. | $23.82 | 2025 | Cvac Aspiration System |
| Srs Medical Systems, INC. | $23.04 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Convatec INC. | $22.09 | 2023 | |
| Alnylam Pharmaceuticals INC. | $21.48 | 2021 | |
| Sagent Pharmaceuticals | $20.59 | 2025 | Glydo |
| Isoray, INC | $18.45 | 2021 | |
| Amag Pharmaceuticals, INC. | $18.32 | 2019 | |
| Hollister Incorporated | $17.50 | 2023 | Infyna Chic, Vapro |
| Medtronic, INC. | $16.99 | 2025 | Interstim |
| Avadel Specialty Pharmaceuticals, LLC | $16.60 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,379,273.85 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.